Clinical Trials on Eosinophilic Pneumonia in Belgium

Total 255 results

Universitaire Ziekenhuizen KU Leuven

Recruiting

Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy (CLE-EoE)

Eosinophilic Esophagitis

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Pediatric Eosinophilic Esophagitis (pedEoE): Effect of Allergen Heat Denaturation on EoE Remission: a Pilot Trial

Eosinophilic Esophagitis

Belgium
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma

Eosinophils, Asthma

United States, Belgium, Canada, Czechia, France, Germany, Hungary, Israel, Poland, Romania, Russian Federation, Spain, Ukraine
AstraZeneca

Active, not recruiting

Patient-reported Outcomes in Real-world Use of Benralizumab in Patients With Severe Eosinophilic Asthma in Belgium (BE-REAL)

Severe Asthma

Belgium
University Hospital, Ghent

Completed

A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy

Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)

Belgium
AstraZeneca

Active, not recruiting

BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging (BURAN)

Asthma

United States, Belgium, United Kingdom, France, Portugal, Australia, Spain
Regeneron Pharmaceuticals
Sanofi

Completed

Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)

Eosinophilic Esophagitis

United States, Australia, Belgium, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
Pfizer
Arena is a wholly owned subsidiary of Pfizer

Completed

A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis (VOYAGE)

Eosinophilic Esophagitis

United States, Spain, Switzerland, Australia, Belgium, Netherlands, Canada, Germany
Calypso Biotech BV

Completed

Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis

Celiac Disease | Eosinophilic Esophagitis

Netherlands, Belgium, Finland, Germany, Norway
GlaxoSmithKline

Completed

Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients

Asthma

United States, Argentina, France, Germany, Spain, Canada, Sweden, Netherlands, Belgium
Sciensano
Merck Sharp & Dohme LLC; Pfizer; Universitaire Ziekenhuizen KU Leuven

Recruiting

Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium (STREPTO)

Pneumonia | Otitis Media | Sinusitis Bacterial

Belgium
AstraZeneca
Amgen

Recruiting

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis (CROSSING)

Eosinophilic Esophagitis

United States, Czechia, Spain, China, Australia, Italy, Belgium, Finland, Norway, Japan, Brazil, Germany, Greece, Canada, Netherlands, Sweden, Israel, Denmark, Austria, Slovakia, New Zealand, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma

Eosinophilic Asthma

United States, Belgium, Colombia, Hungary, Israel, Poland, Sweden, Argentina, Brazil, Canada, France, Mexico, Netherlands
Celgene

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Eosinophilic Esophagitis

Australia, United States, Argentina, Austria, Belgium, Canada, Germany, Israel, Italy, Japan, Poland, Portugal, Spain, Switzerland, United Kingdom
Celgene

Recruiting

Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Eosinophilic Esophagitis

United States, Belgium, Australia, Canada, Italy, Austria, Germany, Israel, Japan, Poland, Portugal, Spain, United Kingdom, Argentina, Switzerland
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma

Eosinophilic Asthma

United States, Australia, Belgium, Chile, Colombia, Czechia, Denmark, Hungary, Israel, Malaysia, New Zealand, Philippines, Poland, Russian Federation, South Africa, Sweden, Thailand
Cliniques universitaires Saint-Luc- Université...

Recruiting

Endothelial Dysfunction in Covid-19 (ENDOCOVID)

Covid19 | Hypoxemic Respiratory Failure

Belgium
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma

Eosinophilic Asthma

United States, Australia, Belgium, Chile, Colombia, Denmark, Hungary, Israel, Malaysia, New Zealand, Philippines, Poland, Russian Federation, South Africa, Sweden, Thailand, Argentina, Brazil, Canada, France, Mexico, Netherlands, Ge... and more
Adare Pharmaceuticals, Inc.

Completed

Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE)

Eosinophilic Esophagitis

Spain, United States, Belgium, Switzerland, Germany, Canada
GlaxoSmithKline

Completed

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control

Asthma

United States, Argentina, Canada, France, Netherlands, Spain, Ukraine, Bulgaria, Estonia, Belgium, Peru, Russian Federation, Germany, Greece, Czechia, Italy, United Kingdom, Norway, Slovakia
Pierre Van Damme
Centre Hospitalier Intercommunal Creteil; University of Bristol; University Ghent and other collaborators

Completed

Carriage of Streptococcus Pneumoniae in Infants With Acute Otitis Media and in Infants Attending Day-care Centers

Streptococcus Pneumoniae | Nasopharyngeal Carriage

Belgium
Novartis Pharmaceuticals

Terminated

A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome

Hypereosinophilic Syndrome

Belgium
Combioxin SA

Completed

Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae

Pneumonia | Pneumococcal Infections

France, Belgium
Bactiguard AB

Completed

VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUs (VITAL)

Ventilator-associated Pneumonia

Belgium
Hasselt University
Ziekenhuis Oost-Limburg

Unknown

Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study (SCOUT)

COVID-19 Pneumonia | Lung Ultrasound

Belgium
KU Leuven

Completed

Improved Use of Antibiotic Guidelines in Hospital Environment

Community-Acquired Pneumonia

Belgium
Sciensano

Completed

COVID-19 Vaccination Uptake in Belgium : Sociodemographic and Socioeconomic Disparities

COVID-19

Belgium
Cliniques universitaires Saint-Luc- Université...
Society for Anesthesia and Resuscitation of Belgium

Completed

Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals (COVID)

COVID-19

Belgium
Jessa Hospital
Hasselt University; University Hospital, Antwerp

Active, not recruiting

Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients (MIA-COVID-19)

COVID-19

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19) (REASSURE)

Covid19

Belgium
Brugmann University Hospital

Completed

Are Surgeons Ready to Get the COVID-19 Vaccine?

Covid19

Belgium
University Hospital, Ghent

Recruiting

The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden

Covid19

Belgium
Dr David DE BELS

Completed

Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19

Covid19

Belgium
Moens Maarten
STIMULUS research group, Vrije Universiteit Brussel

Completed

Profiling of Post Covid-19 Infection Patients: an Online Survey (PRESTO)

Covid19

Belgium
Sciensano
Jessa Hospital

Completed

Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms

COVID-19 | Serology

Belgium
Jessa Hospital

Completed

Predictive Value of SOFA and APACHE Scores for In-hospital Mortality in COVID-19 ICU Patients

Covid19

Belgium
Regeneron Pharmaceuticals

Completed

A Trial to Learn if a COVID-19 Therapeutic is Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants

Healthy

Belgium
Sciensano
Institute of Tropical Medicine, Belgium; Erasme University Hospital; Mensura...

Completed

COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine (REDU-VAC)

Covid19

Belgium
Universiteit Antwerpen
Vrije Universiteit Brussel; Université Libre de Bruxelles; Sciensano

Active, not recruiting

Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium (PREGCOVAC)

Covid19

Belgium
University of Liege
Laboratoires SMB S.A.

Completed

Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection

Covid19

Belgium
Murielle Surquin

Completed

Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age

Covid19

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Surgical Face Mask Effects in Patients With COVID-19

Covid19

Belgium
Jessa Hospital

Completed

Bacterial Surinfections in COVID-19 ICU Patients

Covid19

Belgium
Brugmann University Hospital

Recruiting

Long-term Effects of SARS-CoV-2 on the Central Nervous System and One-year Follow-up of "Long COVID-19" Patients

Long Covid19

Belgium
Hasselt University

Recruiting

Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients (COVID-HO)

Covid-19

Belgium
Hanane EL KENZ

Completed

Reduction of COVID 19 Transmission to Health Care Professionals

COVID 19

Belgium
Jessa Hospital

Completed

Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia

COVID 19

Belgium
Grand Medical Pty Ltd.
Trium Clinical Consulting

Completed

A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia

Severe COVID-19 Pneumonia

Belgium
Universitair Ziekenhuis Brussel

Recruiting

SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector

Covid19 | SARS-CoV-2

Belgium
OSE Immunotherapeutics

Recruiting

To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults (COVEPIT 3)

Coronavirus Disease (COVID-19)

Belgium

Clinical Trials on Eosinophilic Pneumonia in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations